DE69627352D1 - Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten - Google Patents

Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten

Info

Publication number
DE69627352D1
DE69627352D1 DE69627352T DE69627352T DE69627352D1 DE 69627352 D1 DE69627352 D1 DE 69627352D1 DE 69627352 T DE69627352 T DE 69627352T DE 69627352 T DE69627352 T DE 69627352T DE 69627352 D1 DE69627352 D1 DE 69627352D1
Authority
DE
Germany
Prior art keywords
neuropsychiatric diseases
identifying persons
mediated neuropsychiatric
betahemolytic
streptococci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69627352T
Other languages
English (en)
Inventor
E Swedo
L Leonard
J Allen
B Zabriskie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US GOV SEC TECH TRANS
Rockefeller University
National Institutes of Health NIH
Original Assignee
US GOV SEC TECH TRANS
Rockefeller University
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US GOV SEC TECH TRANS, Rockefeller University, National Institutes of Health NIH filed Critical US GOV SEC TECH TRANS
Application granted granted Critical
Publication of DE69627352D1 publication Critical patent/DE69627352D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/301—Anxiety or phobic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Image Processing (AREA)
  • Image Analysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
DE69627352T 1995-06-06 1996-06-06 Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten Expired - Lifetime DE69627352D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47303395A 1995-06-06 1995-06-06
PCT/US1996/009743 WO1996039631A1 (en) 1995-06-06 1996-06-06 METHOD OF IDENTIFYING PERSONS SUSCEPTIBLE TO GROUP A β-HEMOLYTIC STREPTOCOCCI-MEDIATED NEUROPSYCHIATRIC DISORDERS

Publications (1)

Publication Number Publication Date
DE69627352D1 true DE69627352D1 (de) 2003-05-15

Family

ID=23877917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627352T Expired - Lifetime DE69627352D1 (de) 1995-06-06 1996-06-06 Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten

Country Status (10)

Country Link
US (1) US5866347A (de)
EP (1) EP0846267B1 (de)
JP (1) JP2001507440A (de)
AT (1) ATE237139T1 (de)
AU (1) AU697755B2 (de)
CA (1) CA2222737A1 (de)
DE (1) DE69627352D1 (de)
IL (1) IL122426A (de)
NZ (1) NZ310301A (de)
WO (1) WO1996039631A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
US6884591B2 (en) * 2001-06-25 2005-04-26 The Cleveland Clinic Foundation Peripheral marker of blood brain barrier permeability
US7508965B2 (en) * 2004-06-01 2009-03-24 Lumidigm, Inc. System and method for robust fingerprint acquisition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743538A (en) * 1985-04-17 1988-05-10 The Rockefeller University Test for rheumatic fever and monoclonal antibodies useful therefor

Also Published As

Publication number Publication date
MX9709776A (es) 1998-10-31
AU6107396A (en) 1996-12-24
ATE237139T1 (de) 2003-04-15
NZ310301A (en) 1998-12-23
WO1996039631A1 (en) 1996-12-12
CA2222737A1 (en) 1996-12-12
EP0846267A1 (de) 1998-06-10
EP0846267B1 (de) 2003-04-09
IL122426A0 (en) 1998-06-15
IL122426A (en) 2001-01-11
AU697755B2 (en) 1998-10-15
JP2001507440A (ja) 2001-06-05
US5866347A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
DE69220871D1 (de) Vorrichtung und Verfahren zur Auftrennung und Analyse von Vollblut
DE69729473D1 (de) Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE3883701T2 (de) Verfahren und Vorrichtung für multiplexierte Vektorquantifizierung.
NO20092994L (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, fremgangsmate og kit for in vitro diagnose samt fremgangsmate for a identifisere og/eller isolere midler
ATE244018T1 (de) Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer
DE69518834D1 (de) Verfahren und Vorrichtung zur Bestimmung der Erythrozytensedimentationsrate
DE69626683T2 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE3850651T2 (de) Vorrichtung und verfahren zur schnellen detektion von bildfehlehrn.
DE69614958D1 (de) Gerät und Verfahren zur Detektion von Fingerabdruckmerkmalen
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
FR2741518B1 (fr) Appareil pour estimer les fonctions intellectuelles d'une personne
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
DE69021547T2 (de) Vorrichtung und Verfahren zum Feststellen der Echtheit der Handschrift einer Person.
DE69431051T2 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
DE69618451T2 (de) Verfahren zur feststellung einer allergie
DE59706400D1 (de) Verfahren und anordnung zur identifikation von personen
DE69013963D1 (de) Verfahren und Vorrichtung zur Bestimmung des Brechzahlprofils.
DE69104596D1 (de) Vorrichtung und Verfahren für die ständige Diagnose von Turbo-Motoren.
DE69022585D1 (de) Verfahren und Vorrichtung zur Analyse von Formationsflüssigkeiten.
DE69634558D1 (de) Verfahren zur analyse von allergenen
DE29614704U1 (de) Vorrichtung zur Testung neuropsychologischer Merkmale und zur Diagnosefindung sowie zur Kennzeichnung des Verlaufs psychiatrischer Erkrankungen

Legal Events

Date Code Title Description
8332 No legal effect for de